DALLAS, Sept. 20 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP - News) announced today that it has submitted a Premarket Notification 510(k) Application to the United States Food and Drug Administration announcing the Company's intent to market MuGard(TM).
